Asia-Pacific diabetes care drug market is projected to grow at a significant CAGR during the forecast period. The primary factors that are driving the growth of the market include the rising prevalence of diabetes amongst the peoples across the Asia-Pacific region. As per International Diabetes Federation, around 250 million adults in the age range of 20-79 years had diabetes in the region in 2019. China had the highest prevalence of diabetes globally with around 116 million prevalence in 2019. The prevalence of diabetes is estimated to further increase due to increased stress level, sedentary lifestyles, excessive consumption of alcohol, smoking, that elevates body’s sugar levels and in turn leads to diabetes among the human body.
Asia-Pacific diabetes care drugs market is segmented on the basis of drug class into insulin, non-insulin injectable drugs, oral anti-diabetic drugs, and combination drugs. Insulin is the most consumed and favored drug, owing to its fast- and long-action properties. Based on the geographic viewpoint, the Asia-Pacific diabetes care drugs market is segmented into China, India, Japan, and the Rest of Asia-Pacific. China is projected to hold a considerable share in the market owing to the presence of major targeted audiences along with the footprints of major companies.
To Request a Sample of our Report on Asia-Pacific Diabetes Care Drugs Market: https://www.omrglobal.com/request-sample/asia-pacific-diabetes-care-drugs-market
Asia-Pacific Diabetes Care Drugs Market – Segmentation
By Drug Class
- Insulins
- Non-Insulin Injectable Drugs
- Oral Anti-Diabetic Drugs
- Combination Drugs
A full Report of Asia-Pacific Diabetes Care Drugs Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-diabetes-care-drugs-market
Regional Analysis
- Asia-Pacific
- China
- India
- Japan
Rest of Asia-Pacific
Company Profiles
- AstraZeneca Plc
- Bayer AG
- Bausch Health Companies Inc.
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Mylan NV
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceuticals Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-diabetes-care-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
